
    
      A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib
      Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian
      Cancer following First Line Platinum Based Chemotherapy
    
  